Evaluation of ssrA-targeted real time PCR for the detection of Bartonella species in human clinical samples and reflex sequencing for species-level identification.


Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 17 06 2021
revised: 14 10 2021
accepted: 24 10 2021
pubmed: 8 2 2022
medline: 7 6 2022
entrez: 7 2 2022
Statut: ppublish

Résumé

The genus Bartonella includes species capable of causing disease in animals and humans. Due to its fastidious nature, direct detection of Bartonella causing human infection relies largely on molecular microbiological methods. Thus, it is imperative that diagnostic assays in use have the ability to detect a range of Bartonella species associated with human disease. In this study, we compared the performance of a real time polymerase chain reaction (PCR) assay targeting the ssrA gene to conventional rpoB-targeted PCR and sequencing for detection and differentiation of Bartonella species in human clinical samples. The real time ssrA PCR performed better for non-Bartonella henselae species, detecting B. clarridgeiae and B. quintana DNA in heart valve specimens that were not detected by rpoB PCR, and improved the sensitivity of B. henselae detection in blood specimens. Our findings suggest the real time ssrA PCR assay is suitable for detection and identification of Bartonella species in human clinical specimens.

Identifiants

pubmed: 35125201
pii: S0031-3025(22)00026-5
doi: 10.1016/j.pathol.2021.10.014
pii:
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

449-452

Informations de copyright

Copyright © 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Auteurs

Anna Vesty (A)

Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand. Electronic address: AVesty@adhb.govt.nz.

Gillian Henderson (G)

Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand.

Matthew Blakiston (M)

Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand.

Aakash V Chhibber (AV)

Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand.

Andrew Fox-Lewis (A)

Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand.

Sally Roberts (S)

Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand.

Indira Basu (I)

Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH